Clarification Statement
Filed with ASX · · 2 pages · English
Earlier from OncoSil Medical
- Pause in Trading
- FDA Grants Breakthrough Device Designation
- CE Mark Update
- Positive CE Mark Status Report
- OncoSil AGM CEO Presentation
Later from OncoSil Medical
- Oncosil breakthrough device receives CE Marking approval
- Proposed issue of Securities - OSL
- Allotment of Securities under Institutional Placement
- OncoSil receives Singapore regulatory approval
- OncoSil files for TGA registration
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical